Acelot
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
5385 Hollister Ave Ste 111, Santa Barbar...Phone Number
(805) 680-1244Website
www.acelot.comRevenue
<$5 MillionIndustry
About Acelot
Acelot is a biotechnology company focused on developing small molecules to target challenging proteins involved in neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS). Their lead program, ACE-2223, aims to restore the healthy function of the TDP-43 protein, which is critical in the pathology of ALS. The company utilizes advanced AI tools and computational chemistry to design and optimize drug candidates, with the goal of creating first-in-class therapies. Acelot's intended clients include patients suffering from ALS and other neurodegenerative diseases, as well as the broader pharmaceutical industry seeking innovative treatment options.Explore more
Acelot Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Acelot
Compare insights from companies similar to Acelot, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Acelot Tech Stack
A closer look at the technologies used by Acelot
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Acelot
Sign Up For FreeTo access detailed company insights
Acelot is a biotechnology company focused on developing small molecules to target challenging proteins involved in neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS). Their lead program, ACE-2223, aims to restore the healthy function of the TDP-43 protein, which is critical in the pathology of ALS. The company utilizes adv... Read More
